Serum Endothelin-1 Levels in Pediatric Patients After Cardiac Transplantation
MJ
Michael Johansen, DO
Principal Investigator
Status: Enrolling By Invitation
Ages: 100 Years
Gender: All Genders
Phase: N/A
2 Locations
Brief Description
The purpose of this study is to find out more about a substance in the blood, called Endothelin-1, or ET-1, after a child has a heart transplant.
Detailed Description
Blood will be drawn once during participants' heart catheterization. The study team will collect information from participants' medical records.
Eligibility of study
Individuals with a history of prior cardiac transplantation that was completed before 18 years of age.
Individuals with moderate to severe pulmonary hypertension or cardiac transplantation that was within 180 days will not be eligible.
Interested in participating?
Enrollment in IU School of Medicine clinical trials is managed through our All IN for Health program. Many studies only accept people who are part of an invited group. Visit allinforhealth.info to connect with the study team, or contact your doctor to see if you are eligible.